Home » Authors » Jim Shrine

Jim Shrine

Articles

ARTICLES

Swiss Firm GlycoVaxyn Raises $9.5M For Vaccine Programs

July 17, 2007

Swiss Firm GlycoVaxyn Raises $9.5M For Vaccine Programs

July 17, 2007

CODA Raises $7M In Series C For Protein Expression Platform

July 12, 2007

CODA Raises $7M In Series C For Protein Expression Platform

July 12, 2007

CureVac Completes €35M Round For mRNA Product Development

July 11, 2007

CureVac Completes 35M Round For mRNA Product Development

July 11, 2007

No Abstract

Reata Raises $25M In Series E To Fund Development Programs

July 9, 2007

Reata Raises $25M In Series E To Fund Development Programs

July 9, 2007

ViroPharma Starts Phase III Trial Of Camvia In Liver Transplants

July 6, 2007

ViroPharma Starts Phase III Trial Of Camvia In Liver Transplants

July 6, 2007

View All Articles by Jim Shrine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 9, 2025.
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
AACR 2025: Induced proximity strategy, beyond degraders
BioWorld
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
NME Digest: Q1 2025
BioWorld
A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...